2025 CPT code 80150
(Active) Effective Date: N/A Revision Date: N/A Laboratory - Therapeutic Drug Assays Pathology and Laboratory Procedures Feed
Quantitative analysis of amikacin levels in a patient specimen (e.g., serum, plasma).
Modifiers might be applied to code 80150 to reflect factors such as the location of service, the type of laboratory performing the test (e.g., outside lab), or multiple tests performed. Consult the current CPT manual for guidance on modifier usage.
Medical necessity for amikacin level testing (80150) is established when a patient is receiving amikacin therapy for a serious bacterial infection.Monitoring is essential to optimize therapeutic efficacy and prevent nephrotoxicity and ototoxicity.Frequency of testing depends on factors like renal function, patient age, and clinical response. Documentation supporting the need for amikacin therapy must exist to ensure the testing is appropriate.
The clinical responsibility for this test lies primarily with the laboratory personnel who perform the analysis. The ordering physician is responsible for the medical decision to order the test and interpret the results. The collecting provider might have a separate responsibility for obtaining the patient sample.
In simple words: This lab test measures the amount of amikacin, an antibiotic, in your blood to make sure you're getting the right dose and to avoid harmful side effects.
This CPT code, 80150, represents the analytical procedure to quantitatively determine the concentration of amikacin in a biological specimen obtained from a patient.The specimen may include serum, plasma, whole blood, or cerebrospinal fluid. The method of analysis is typically an immunoassay such as ELISA. The test measures the parent drug and includes metabolites if detected. Results are crucial for therapeutic drug monitoring, ensuring appropriate amikacin dosing and preventing toxicity.
Example 1: A patient presents with a serious bacterial infection and is prescribed amikacin.Regular amikacin level testing (using code 80150) is ordered to monitor drug levels and avoid toxicity. Trough levels are measured before each dose., A neonate is being treated for sepsis with amikacin. Because of the risk of nephrotoxicity in this age group, frequent amikacin level monitoring is vital. Peak and trough levels are drawn, and the results guide dosage adjustments. , A patient with compromised renal function is receiving amikacin. The physician uses 80150 to closely monitor serum amikacin levels and adjust the dosing regimen based on creatinine clearance and drug concentration to minimize the risk of adverse effects.
* Physician order specifying the test (amikacin level).* Patient demographics and relevant medical history (renal function, allergies, etc.).* Specimen collection date and time (including peak or trough specification).* Specimen type (serum, plasma, etc.).* Lab results indicating amikacin concentration.* Date and time of the test analysis.
** The use of code 80150 necessitates careful attention to specimen handling and analytical technique to ensure accurate and reliable results. Results should be interpreted in the context of the patient's clinical status and renal function.
- Revenue Code: T1H (LAB TESTS - OTHER (NON-MEDICARE FEE SCHEDULE))
- Payment Status: Active
- Specialties:Infectious Disease, Nephrology, Clinical Microbiology, Pharmacy
- Place of Service:Office, Hospital (Inpatient or Outpatient), Laboratory